A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

The social impairments of autism spectrum disorder (ASD) have a major impact on quality of life, yet there are no medications that effectively treat these core social behavior deficits. Preclinical research suggests that arginine vasopressin (AVP), a neuropeptide involved in promoting mammalian soci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Transl Med
Main Authors: Parker, Karen J., Oztan, Ozge, Libove, Robin A., Mohsin, Noreen, Karhson, Debra S., Sumiyoshi, Raena D., Summers, Jacqueline E., Hinman, Kyle E., Motonaga, Kara S., Phillips, Jennifer M., Carson, Dean S., Fung, Lawrence K., Garner, Joseph P., Hardan, Antonio Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716148/
https://ncbi.nlm.nih.gov/pubmed/31043522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aau7356
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados